(Q39149556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

William Vainchenker

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Fawzia Louache

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Eric Solary

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

A Bouchekioua

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

L Scourzic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

O de Wever

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Y Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P Cervera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A Aline-Fardin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P Gaulard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

R Nyga

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

D Jeziorowska

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

L Douay

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Gespach

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P Coppo

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

21 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

338-348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2013.157

1 March 2020

exact match

0 references

cites work

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

PRDM1 is a tumor suppressor gene in natural killer cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Frequent mutations of Fas gene in nasal NK/T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Modeling and quantification of cancer cell invasion through collagen type I matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Activating alleles of JAK3 in acute megakaryoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Activating mutations in human acute megakaryoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

IL-9 and its receptor: from signal transduction to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

JAK kinases overexpression promotes in vitro cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

JAK3: a two-faced player in hematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Identification of NPM-ALK interacting proteins by tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Cancer invasion and the microenvironment: plasticity and reciprocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.157

Invasion-associated genes identified by gene expression profiling in extranodal natural killer/T-cell lymphoma, nasal type

21 January 2018

1 reference

12 December 2020

Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus

1 reference

12 December 2020

Classification of cytotoxic T-cell and natural killer cell lymphomas

1 reference

12 December 2020

Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2013.157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23689514%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference